NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil.
In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture
Conference Level For NCI Is 5.4% Over FY 1990
Robert Weinburger, Ernst Wynder Win Top Milken Awards
NCI Stops Trial Of Screening In Men To Add Women
Antoine To Leave As RP Director, Will Join ROB
DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
